AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102
AI and Machine Learning in Pharmaceutical Drug Development – Asrar Qureshi’s Blog Post #1102 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1102 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here. Credit: cottonbro studio Credit: Rui Dias Credit: YI REN This blogpost is inspired by interview of GSK’s Global Head of AI and Machine Learning, Kim Branson, by McKinsey panel. Link at the end Preamble The pharmaceutical industry is undergoing a profound transformation. With rising R&D costs, extended development timelines, and increasing regulatory scrutiny, innovation is no longer optional—it is essential. Among the most disruptive enablers of this transformation are Artificial Intelligence (AI) and Machine Learning (ML). These technologies are rapidly changing the way drugs are discovered, developed, and delivered. From e...